abstract |
Provided herein are, inter alia, compositions, methods and kits for treating inflammatory skin disorders using histamine antagonists. In certain embodiments, the compositions, methods, and kits are intended for the treatment of urticaria and symptoms thereof. In certain embodiments, the compositions, methods, and kits include a topical pharmaceutical preparation that includes an effective amount of alcaftazine as the active agent. [Selection figure] None |